Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Metagenomi Therapeutics, Inc. | 109,135 | reported | 06 Jun 2025 | tx 5+398,638−5,239 |
| PROTHENA CORP PUBLIC LTD CO | 100,000 | reported | 16 May 2017 | tx 1+100,000 |
| Protagonist Therapeutics, Inc | 30,000 | reported | 16 Jan 2023 | tx 15+163,400−16,800 |
| MARINUS PHARMACEUTICALS INC | 14,100 | reported | 18 Jun 2024 | tx 6+77,850 |
| Neurogene Inc. | 12,050 | reported | 20 Feb 2026 | tx 9+169,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | GRANT_AWARD | Neurogene Inc. | 12,050 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Neurogene Inc. | 12,050 | 0.00 USD | deriv |
| 06 Jun 2025 | SALE | Metagenomi Therapeutics, Inc. | 5,239 | 1.75 USD | |
| 01 Apr 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 14,000 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 84,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | MARINUS PHARMACEUTICALS INC | 2,300 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | MARINUS PHARMACEUTICALS INC | 10,450 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | Neurogene Inc. | 7,700 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 57,763 | 0.00 USD | |
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 242,875 | 0.00 USD | deriv |
| 18 Jan 2024 | GRANT_AWARD | MARINUS PHARMACEUTICALS INC | 4,600 | 0.00 USD | |
| 18 Jan 2024 | GRANT_AWARD | MARINUS PHARMACEUTICALS INC | 20,900 | 0.00 USD | deriv |
| 16 Jan 2024 | GRANT_AWARD | Neurogene Inc. | 15,400 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Neurogene Inc. | 25,000 | 0.00 USD | deriv |
| 16 May 2023 | GRANT_AWARD | MARINUS PHARMACEUTICALS INC | 7,200 | 0.00 USD | |
| 16 May 2023 | GRANT_AWARD | MARINUS PHARMACEUTICALS INC | 32,400 | 0.00 USD | deriv |
| 16 Jan 2023 | GRANT_AWARD | Protagonist Therapeutics, Inc | 30,000 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Protagonist Therapeutics, Inc | 20,000 | 0.00 USD | deriv |
| 12 May 2022 | GRANT_AWARD | Neurogene Inc. | 25,000 | 0.00 USD | deriv |
| 27 May 2021 | GRANT_AWARD | Protagonist Therapeutics, Inc | 18,000 | 0.00 USD | deriv |
| 11 May 2021 | GRANT_AWARD | Neurogene Inc. | 25,000 | 0.00 USD | deriv |
| 11 Feb 2021 | GRANT_AWARD | Protagonist Therapeutics, Inc | 3,700 | 6.98 USD | |
| 11 Feb 2021 | SALE | Protagonist Therapeutics, Inc | 3,700 | 25.09 USD | |
| 10 Feb 2021 | SALE | Protagonist Therapeutics, Inc | 400 | 26.04 USD | |
| 10 Feb 2021 | GRANT_AWARD | Protagonist Therapeutics, Inc | 4,700 | 6.98 USD |